45
Participants
Start Date
August 31, 2000
Primary Completion Date
February 28, 2007
Study Completion Date
February 28, 2009
semaxanib
Michiana Hematology/Oncology P.C., South Bend
Division of Hematology/Oncology, Park Ridge
Evanston Northwestern Health Care, Evanston
University of Illinois at Chicago, Chicago
Louis A. Weiss Memorial Hospital, Chicago
Oncology/Hematology Associates of Central Illinois, P.C., Peoria
Cancer Care Specialists of Central Illinois, S.C., Decatur
Central Illinois Hematology Oncology Center, Springfield
University of Chicago Cancer Research Center, Chicago
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
National Cancer Institute (NCI)
NIH